Rocio Nieto
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer.
Journal: Cancers
Published: December 26, 2022
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.
Journal: Cancers
Published: September 05, 2019
Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis.
Journal: Clinical epigenetics
Published: July 17, 2019
Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 16, 2019
Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer.
Journal: British journal of cancer
Published: March 09, 2017
Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.
Journal: Scientific reports
Published: October 06, 2016
Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.
Journal: Scientific reports
Published: June 24, 2015
Myo5b knockout mice as a model of microvillus inclusion disease.
Journal: Scientific reports
Published: March 24, 2015
Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 29, 2014
RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.
Journal: Nature communications
Published: May 05, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026